As of Monday, the S&P 500 has been trading above its 20-day moving average for 55 days. That's the longest stretch since ...

BTIG upgraded Synchrony Financial (NYSE:SYF) and Bread Financial (NYSE:BFH) to Buy, Ally Financial (NYSE:ALLY) to Neutral and ...

I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision ...

BTIG downgraded shares of Affirm and PROG Holdings ahead of second-quarter earnings, flagging concerns over weakening credit trends and increased competition from traditional lenders. Brokerage ...

Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...

Billionaire Kerr Neilson has bought over $8 million worth of shares in Flutter Entertainment plc (NYSE:FLUT), representing ...

BTIG downgraded AFRM to "neutral" from "buy" Though shares of buy-now-pay-later name Affirm Holdings Inc (NASDAQ:AFRM) have pared some of their premarket losses, the equity remains down 1% at $64.06, ...

Brokerage firm BTIG LLC accused StoneX Group Inc., a rival brokerage and investment bank, of stealing its proprietary software code in what its lawyers describe as “one of the greatest financial ...

U.S. brokerage firm BTIG on Monday sued rival StoneX Group Inc in San Francisco, accusing it of stealing trade secrets and seeking at least $200 million in damages.

BTIG sees increased stability for the medtech sector in 2024, helped by election year dynamics, as it makes its top stock picks for the coming year. Read more here.

BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...

In a research report last week, BTIG argued that Expedia is on the cusp of narrowing the profit gap with Booking Holdings.